← Back to Search

Behavioral Intervention

IDS Interventions for Infant Development

N/A

Waitlist Available

Research Sponsored by Northwestern University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Must speak English or Dagbani (a language local to Tamale and the surrounding areas)

Must be age 18 to 40 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 10 hours

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing whether or not talking to infants encourages language and brain development.

Who is the study for?

This trial is for women aged 18-40 in Tamale, Ghana, who are pregnant or have infants aged 2-18 months. Participants must visit local health facilities and speak English or Dagbani. It's designed to help mothers learn how to improve their babies' language and brain development through talking.

What is being tested?

The study tests a simple strategy using videos and wall calendars to encourage mothers to engage more with their infants through infant-directed speech (IDS), which could benefit the child's early development.

What are the potential side effects?

There are no medical side effects associated with this intervention as it involves educational materials rather than medication or clinical treatments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I speak English or Dagbani.

Select...

I am between 18 and 40 years old.

Select...

I am between 2 and 18 months old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 10 hours

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~10 hours

This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Adult word count

Number of conversational turns

Self-reported parental IDS behavior (Index)

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Infant Directed Speech (IDS) Video + IDS CalendarExperimental Treatment1 Intervention

The participant will be shown a 3-minute video describing the value of IDS and how the participant can use IDS with their child. The participant will receive an IDS-themed wall calendar.

Group II: ControlActive Control1 Intervention

No intervention. The participant will receive a regular wall calendar with an image of Stanford.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Infant Directed Speech (IDS) Video + IDS Wall Calendar

2021

N/A

~2800

0 / 3Eligibility criteria met